Inreda Diabetic Overview

  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Investors
  • 1

Inreda Diabetic General Information


Developer of a bi-hormonal artificial pancreas device designed to autonomously regulate the glucose level in the blood of patients with diabetes at home. The company's device performs a real-time regulation of glucose concentration in the blood and if needed, or infuse glucose to lower the blood glucose level, or infuse glucagon to raise it, enabling users to improve both quality of treatment and quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • Klavermaten 65-5
  • 7472 DD
  • Netherlands
+31 0547 000 000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Inreda Diabetic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) Completed Startup
To view Inreda Diabetic’s complete valuation and funding history, request access »

Inreda Diabetic Executive Team (1)

Name Title Board Seat Contact Info
Robin Koops Founder
To view Inreda Diabetic’s complete executive team members history, request access »

Inreda Diabetic Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
UvA Ventures Holding Venture Capital Minority 000 0000 000000 0
To view Inreda Diabetic’s complete investors history, request access »